Jefferies is keeping their Buy rating on ARIAD Pharmaceuticals (NASDAQ: ARIA) as the company's partner, Merck (NYSE: MRK), is going ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE